Literature DB >> 24974212

Pancreatic neuroendocrine tumor in a child of 3.5 years old.

Shirin Sayyahfar1,2, Seyed Javad Nassiri3,4, Mitra Mehrazma3,5, Mahnaz Sadeghian3,6.   

Abstract

BACKGROUND: Pancreatic neuroendocrine tumor is rarely seen, particularly in children. One of the symptoms of this tumor is jaundice that may be misdiagnosed as the sign of hepatitis A, especially in countries with a high prevalence of this infectious disease.
METHODS: We present a 3.5-year-old girl with four weeks of icterus, who was misdiagnosed with hepatitis A.
RESULTS: The patient was finally diagnosed as having a low grade pancreatic neuroendocrine carcinoma.
CONCLUSION: Pediatricians should be aware of or consider a tumor in differential diagnosis of jaundice, especially prolonged one in children.

Entities:  

Keywords:  hepatitis A; icterus; neuroendocrine tumor; pancreatic tumor

Mesh:

Year:  2014        PMID: 24974212     DOI: 10.1007/s12519-014-0491-z

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  7 in total

1.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation.

Authors:  Rudolf Arnold; Yuan-Jia Chen; Frederico Costa; Massimo Falconi; David Gross; Ashley B Grossman; Rudolf Hyrdel; Beata Kos-Kudła; Ramon Salazar; Ursula Plöckinger
Journal:  Neuroendocrinology       Date:  2009-08-28       Impact factor: 4.914

Review 2.  Neuroendocrine tumors of the gastro-entero-pancreatic system.

Authors:  Sara Massironi; Valentina Sciola; Maddalena Peracchi; Clorinda Ciafardini; Matilde Pia Spampatti; Dario Conte
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

3.  Complications after pancreatectomy for neuroendocrine tumors: a national study.

Authors:  Jillian K Smith; Sing Chau Ng; Joshua S Hill; Jessica P Simons; Edward J Arous; Shimul A Shah; Jennifer F Tseng; Theodore P McDade
Journal:  J Surg Res       Date:  2010-05-09       Impact factor: 2.192

Review 4.  A fuller understanding of pancreatic neuroendocrine tumours combined with aggressive management improves outcome.

Authors:  S L Ong; G Garcea; C A Pollard; P N Furness; W P Steward; A Rajesh; L Spencer; D M Lloyd; D P Berry; A R Dennison
Journal:  Pancreatology       Date:  2009-08-04       Impact factor: 3.996

5.  Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas.

Authors:  L Fischer; J Kleeff; I Esposito; U Hinz; A Zimmermann; H Friess; M W Büchler
Journal:  Br J Surg       Date:  2008-05       Impact factor: 6.939

6.  Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?

Authors:  Laureano Fernández-Cruz; Laia Blanco; Rebeca Cosa; Héctor Rendón
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

7.  EUS-FNA for a Pancreatic Neuroendocrine Tumor in a Four-Year-Old Daughter of a Woman Exposed to Radiation at Chernobyl.

Authors:  Jesse Lachter; Marc S Arkovitz; Sergey Postovski; Julian M Waldner; Ron Shaoul; Offir Ben Ishay; Yoram Kluger
Journal:  Case Rep Gastrointest Med       Date:  2012-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.